While cancer cells upregulated endogenous fibroblast growth factor (FGF)-2 and became spontaneously resistant to a kinase inhibitor drug vemurafenib when cultured inside microchambers64, mouse embryonic stem cells maintained pluripotency inside microchambers by producing endogenous leukemia inhibitory factor (LIF)65. This evidence concerns the gene LIF and cancer.